RTGN News Alert Ruthigen Inc. (RTGN) 3.65 12/25/2014 08:18:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ruthigen Inc. (RTGN) 3.65 $RTGN

Strong Portfolio, Dividends Make Merck An Attractive Opportunity
Kanak Kanti De - at Seeking Alpha - Mon Dec 08, 2:40PM CST

TTPH: 38.86 (+0.53), CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), RTGN: 3.65 (+0.10)

Ruthigen EPS of -$0.35
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 3:46PM CST

RTGN: 3.65 (+0.10)

Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015
GlobeNewswire - Thu Nov 13, 3:08PM CST
-- Total revenue of $3.3 million for the second quarter
OCLS: 1.50 (+0.01), RTGN: 3.65 (+0.10)

Ruthigen Reports Fiscal Second Quarter 2015 Financial Results
PR Newswire - Thu Nov 13, 3:01PM CST
Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fiscal second quarter 2015 ended September 30, 2014.
RTGN: 3.65 (+0.10)

Ruthigen To Hold Fiscal Second Quarter 2015 Financial Results Conference Call On Thursday, November 13, 2014
PR Newswire - Thu Nov 06, 6:00AM CST
Ruthigen, Inc., (NASDAQ: RTGN) today announced that the financial results for its fiscal second quarter 2015, ended September 30, 2014, will be released after the U.S. markets close on November 13, 2014. The earnings release will be followed by a conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on November 13, 2014, to discuss fiscal second quarter 2015 results.
RTGN: 3.65 (+0.10)

Ruthigen Announces First Patient Enrollment in the Phase 1/2 Human Clinical Trial of RUT58-60, a Broad-Spectrum Anti-Infective Drug Candidate Designed for Prophylactic Use During Invasive Surgery
PR Newswire - Tue Nov 04, 6:00AM CST
Ruthigen, Inc. (NASDAQ: RTGN), announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
RTGN: 3.65 (+0.10)

Nasdaq stocks posting largest percentage increases
AP - Tue Oct 21, 12:44PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
EGLT: 5.97 (+0.21), XPLR: 6.60 (+0.06), ILMN: 186.22 (+2.72), SYNL: 17.08 (+0.15), QVCB: 27.06 (-1.70), CZR: 15.44 (+0.20), QVCA: 29.36 (-0.12), ORPN: 6.25 (-0.35), SHLD: 32.56 (-0.37), RTGN: 3.65 (+0.10)

Ruthigen Initiates Phase 1/2 Clinical Trial of RUT58-60
PR Newswire - Wed Oct 08, 6:00AM CDT
Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
RTGN: 3.65 (+0.10)

IPO Value Surges To The Highest Level In More Than a Decade
ACCESSWIRE - Fri Sep 19, 11:52AM CDT
Deerfield Beach, FL / September 19, 2014 / As the U.S. economy continues to recover, deal making activity has surged. Indeed, both M&As and initial public offerings (IPO) have seen a surge this year. In fact data from Dealogic shows that companies raised $46.4 billion in the first eight months of 2014, the highest of any year since 2000. The value of IPOs will get a huge boost as Chinese e-commerce company Alibaba Group Holding Ltd. (NYSE: BABA) completed its IPO on Thursday.
RICE: 22.41 (-0.33), FB: 80.77 (+0.16), FOMX: 6.35 (-0.15), RSPP: 26.14 (-0.09), RTGN: 3.65 (+0.10), BABA: 105.95 (+0.43)

Ruthigen to Present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York City
PR Newswire - Thu Sep 04, 6:00AM CDT
Ruthigen, Inc., (NASDAQ: RTGN) a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company is scheduled to present at the Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at 2:30 p.m. ET. The conference will be held at the New York Palace Hotel in New York City.
RTGN: 3.65 (+0.10)

Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60
PR Newswire - Tue Aug 26, 6:00AM CDT
Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee (DMC) to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
RTGN: 3.65 (+0.10)

Biotechnology Stocks to Keep an Eye On
ACCESSWIRE - Wed Aug 20, 8:01AM CDT
Deerfield Beach, FL / Aug 20, 2014 / It has been a disappointing year for biotechnology stocks so far after last year's surge. The correction was expected after last year's surge; however, the losses were accentuated after Fed Chair Janet Yellen's comments earlier this year regarding a possible bubble in biotech and social media stocks.
ACHN: 13.06 (+1.22), AVEO: 0.82 (+0.01), AEGR: 21.59 (-0.27), RTGN: 3.65 (+0.10)

Ruthigen Reports Fiscal First Quarter 2015 Financial Results
PR Newswire - Thu Aug 14, 3:17PM CDT
Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fiscal first quarter 2015 ended June 30, 2014.
RTGN: 3.65 (+0.10)

Ruthigen To Hold Fiscal First Quarter 2015 Financial Results Conference Call On Thursday, August 14, 2014
PR Newswire - Thu Aug 07, 3:45PM CDT
Ruthigen, Inc., (NASDAQ: RTGN) today announced that the financial results for its fiscal first quarter 2015, ended June 30, 2014, will be released after the U.S. markets close on August 14, 2014. The earnings release will be followed by a conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on August 14, 2014, to discuss fiscal first quarter 2015 results.
RTGN: 3.65 (+0.10)

Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015
GlobeNewswire - Thu Aug 07, 3:42PM CDT
-- Net loss of $70,000, reduced $1.6 million from same period last year
OCLS: 1.50 (+0.01), RTGN: 3.65 (+0.10)

Biotechnology Sector in Focus
ACCESSWIRE - Thu Jul 31, 8:01AM CDT
Deerfield Beach, FL / ACCESSWIRE / July 31, 2014 / One of the major concerns for big pharma is patent expirations. Patent expirations will result in a loss of $34 billion in revenue at big pharma companies this year. This was after pharma companies lost $55 billion and $28 billion in revenue in 2012 and 2013, respectively. In 2015, products worth $66 billion will see their patents expire.
TTPH: 38.86 (+0.53), SYN: 1.46 (-0.07), IMUC: 0.68 (unch), SIGA: 1.43 (-0.03), RTGN: 3.65 (+0.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Subsplash Builds a Broader Church Software Stack in 2026

Updated Category News Views 113

Church software has spent too many years behaving like a junk drawer, and Subsplash is plainly trying to replace it with one working system. The company used its November 18 Product Event in Dallas to show off releases from 2026 and preview two additions: Communications, due in December, and Subsplash Intelligence, targeted for early 2027. A Serious Push Beyond the Church...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 86

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 77

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading
Atalanta Takes Formal Verification Into Critical Systems

Updated Category News Views 426

A week of bewildering infrastructure failures is a nasty time to discover nobody can explain the machinery. That was the backdrop for Atalanta CEO and co-founder Anjana Rajan at the National Academies of Sciences, Engineering, and Medicine's Cyber Resilience Forum, which concluded November 20 after two days in Washington. Her central point deserves more attention than the...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 127

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Union Pacific Faces $98.8 Million Arbitration Tab

Updated Category News Views 133

A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...

Continue Reading
Lennar's 6.73% Slide Puts Disclosure Claims in Focus

Updated Category News Views 73

A homebuilder can survive ugly margins; murky demand signals are another beast entirely. Lennar is staring at a securities class action after a bruising run of disclosures and market reactions, and the central issue is not whether housing got tougher. Everybody with a pulse knew rates were squeezing buyers. The issue is whether NYSE:LEN gave investors a sufficiently clear...

Continue Reading

Top 5 Most Recently Viewed Articles

RPM International Reports Strong Sales Amid Tariff Challenges

Updated Category News Views 147

RPM International Achieves Notable Sales Growth RPM International Inc. (NYSE: RPM) has recently announced a significant financial performance, showcasing record sales during its first fiscal quarter. The company reported an impressive $2.11 billion in sales, marking a 7.4% increase from $1.97 billion in the same quarter of the previous year, surpassing estimates of $2.057...

Continue Reading
Growing CRM Market Driven by AI: Insights for 2024-2028

Updated Category News Views 122

CRM Market Shift: Embracing AI and SME Adoption The global CRM market is experiencing significant growth, projected to increase by USD 60 billion between 2024 and 2028. This robust expansion reflects a compound annual growth rate (CAGR) of 10.23%. A major contributor to this trend is the growing acceptance of customer relationship management (CRM) systems among small and...

Continue Reading
Rexel Announces Key Changes in Executive Leadership Team

Updated Category News Views 586

Leadership Appointments at Rexel Rexel, a leader in the multichannel distribution of energy solutions, has recently made significant appointments to its Group Executive Committee. These changes signify the company's commitment to innovation and strategies that drive transformation in their markets. New Responsibilities and Key Appointments A notable change is the...

Continue Reading
Strike Performance Footwear: Innovation for Passionate Anglers

Updated Category News Views 141

Revolutionizing Angling Footwear with Strike The world of fishing is about to be transformed with the introduction of Strike, a performance footwear brand designed by anglers, for anglers. This innovative brand stands out for its commitment to sustainability without compromising on comfort and performance. Whether you are on the water, on deck, or by the shore, Strike...

Continue Reading
Ascentage Pharma Plans 2025 Mid-Year Results Release and Update

Updated Category News Views 216

Ascentage Pharma to Release 2025 Interim Results Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) is on the verge of a significant update for stakeholders and investors. The company, recognized for its commitment to addressing unmet needs in cancer treatment, has announced plans to unveil their unaudited interim results for the first six months of 2025....

Continue Reading